The World Antiviral Congress returns this year to San Diego on November 28th – December 1st.
This is your chance to hear from academic and industry leaders as the conference brings together all the global antiviral experts and senior executives under one roof. The agenda is supported and shaped by the expert Scientific Advisory Board.
Take advantage of the super early bird – register now to save $800 and get your ticket for only $1495.
This is the most critical time in history for the global drug discovery and development community to come together.
Evident with every viral pandemic including COVID-19, rapid deployment of compatible antiviral therapies is of paramount importance, particularly as new viral variants occur that could still evade vaccines.
Antivirals can prevent or control viral diseases from emerging diseases, respiratory infections, chronic diseases to virus-associated tumours. Join us at the congress to get up to speed and help accelerate your antiviral research from bench to patient.
With hundreds of potential customers in attendance there will be opportunities to meet & network with contacts who are looking for solutions to commercial and scientific challenges in manufacturing, clinical trials, influenza, retrovirus, antiviral therapies and much more.
We will identify the urgent priorities for research, to mobilize, coordinate and align funding to enable the research needed to tackle this crisis. Join us to learn mechanisms for continuing scientific interactions and collaborations, now and beyond the congress.
NEW BENEFITS:
- Larger attendance of experts in infectious disease and cancer immunotherapy
- A more holistic event that looks at how disease (including COVID-19) is managed preventatively and therapeutically
- See how vaccines, antivirals and antibodies all play a part in managing and preventing disease
- More networking and partnering opportunities with extended breaks and evening receptions
